Jane Figueiredo appointed co-leader of Cancer Prevention and Control Program at Cedars-Sinai

Gene-based blood test for melanoma may detect early signs of cancer return

Monitoring blood levels of DNA fragments shed by dying tumor cells may accurately predict skin cancer recurrence, a recent study led by researchers at NYU Langone Health and its Perlmutter Cancer Center shows.

April 18, 2025

Vol.51 No.15

Clinical Roundup

Even light daily physical activity linked to lower cancer risk, NIH and Oxford study shows

In a prospective cohort study of more than 85,000 adults in the UK, researchers at the NIH and University of Oxford found that individuals who engaged in light- and moderate-to-vigorous-intensity daily physical activity had a lower risk of cancer than individuals who were more sedentary.

March 28, 2025

Vol.51 No.12

Clinical Roundup

UT Health San Antonio-led research discovers how to slow or block recurrence of glioblastoma

Researchers at the University of Texas Health Science Center at San Antonio have discovered a way to delay or even block recurrence of the deadliest brain cancer after radiation.

March 28, 2025

Vol.51 No.12

Clinical Roundup

Mutated cells can persist for years without becoming cancer and need an inflammatory “push” for malignancy to occur, COH study shows

Researchers at City of Hope have found that cell mutations are necessary but not always sufficient for tumors to form. Instead, they suggest that additional risk factors that promote tumor growth, like chronic inflammation, are a key trigger for tumor formation.

March 28, 2025

Vol.51 No.12

Clinical Roundup

Tumor-invading protein delivers therapy straight to the brain, study finds

A protein designed by Cedars-Sinai Cancer investigators can cross the protective blood-brain barrier safely and deliver therapy directly into cancerous tumor cells, a preclinical study shows.

February 28, 2025

Vol.51 No.08

In Brief

Ze’ev Ronai receives NCI Outstanding Investigator Award

Ze’ev Ronai, a cancer investigator and director of the Translational Research Institute at Cedars-Sinai, received an Outstanding Investigator Award from NCI.

February 21, 2025

Vol.51 No.07

Jane Figueiredo appointed co-leader of Cancer Prevention and Control Program at Cedars-Sinai

YOU MAY BE INTERESTED IN

Gene-based blood test for melanoma may detect early signs of cancer return

Even light daily physical activity linked to lower cancer risk, NIH and Oxford study shows

UT Health San Antonio-led research discovers how to slow or block recurrence of glioblastoma

Mutated cells can persist for years without becoming cancer and need an inflammatory “push” for malignancy to occur, COH study shows

Tumor-invading protein delivers therapy straight to the brain, study finds

Ze’ev Ronai receives NCI Outstanding Investigator Award

Renew today!

Subscriber content

Never miss an issue!

Login